http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 15 Jun 2026 08:02:06 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Shannon+Trevi%C3%B1o+as+general+counsel/26644492.html <p>SpyGlass Pharma Inc. (NASDAQ: SGP) appointed Shannon Treviño as general counsel, the biopharmaceutical company announced June 15.</p><p>Treviño previously served as general counsel and corporate secretary at Inari Medical, where she oversaw legal and compliance functions during the company's $4.9 billion acquisition by Stryker. She also managed Inari's acquisition of LimFlow and its integration.</p><p>Before joining Inari, Treviño worked as an attorney at Sugg Law Group, advising early and growth-stage companies on governance, commercial contracts, capital formation and mergers and acquisitions. She spent eight years as a clinical professor and director of the Transactional Lawyering Institute at Loyola Marymount University's Law School, http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Shannon+Trevi%C3%B1o+as+general+counsel/26644492.html Mon, 15 Jun 2026 08:02:06 -0400 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html <p>ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth.</p> <p>“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” said Patrick Mooney, CEO of SpyGlass Pharma. “The team we are building at SpyGlass is http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Shannon+Trevi%C3%B1o+as+General+Counsel/26644419.html Mon, 15 Jun 2026 08:00:00 -0400 A.06822034 A.09399774 A.50114142 O.00048820 O.20026344 O.47578892 SGP http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html <p>SpyGlass Pharma Inc. (NASDAQ: SGP) appointed Mike Pinder as vice president of marketing, the company announced. Pinder brings more than 20 years of commercial launch experience in ophthalmology.</p> <p>At SpyGlass Pharma, Pinder will build and lead the marketing function as the company progresses its Bimatoprost Drug Pad-IOL System through Phase 3 clinical trials toward potential commercialization upon FDA approval.</p> <p>Pinder was most recently head of IZERVAY marketing at Astellas Pharma. He previously led patient marketing in the Novartis ophthalmology retina franchise and held hospital marketing positions at Johnson & Johnson. He holds a Bachelor of Arts degree in communications from the University http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html Tue, 02 Jun 2026 08:01:01 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html <p>SpyGlass Pharma Inc. (NASDAQ: SGP) appointed Mike Pinder as vice president of marketing, the company announced. Pinder brings more than 20 years of commercial launch experience in ophthalmology.</p> <p>At SpyGlass Pharma, Pinder will build and lead the marketing function as the company progresses its Bimatoprost Drug Pad-IOL System through Phase 3 clinical trials toward potential commercialization upon FDA approval.</p> <p>Pinder was most recently head of IZERVAY marketing at Astellas Pharma. He previously led patient marketing in the Novartis ophthalmology retina franchise and held hospital marketing positions at Johnson & Johnson. He holds a Bachelor of Arts degree in communications from the University http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html Tue, 02 Jun 2026 08:01:01 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html <p>SpyGlass Pharma Inc. (NASDAQ: SGP) appointed Mike Pinder as vice president of marketing, the company announced. Pinder brings more than 20 years of commercial launch experience in ophthalmology.</p> <p>At SpyGlass Pharma, Pinder will build and lead the marketing function as the company progresses its Bimatoprost Drug Pad-IOL System through Phase 3 clinical trials toward potential commercialization upon FDA approval.</p> <p>Pinder was most recently head of IZERVAY marketing at Astellas Pharma. He previously led patient marketing in the Novartis ophthalmology retina franchise and held hospital marketing positions at Johnson & Johnson. He holds a Bachelor of Arts degree in communications from the University http://www.streetinsider.com/Management+Changes/SpyGlass+Pharma+names+Mike+Pinder+as+VP+of+marketing/26587786.html Tue, 02 Jun 2026 08:01:01 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html <p>ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as vice president, marketing. Mr. Pinder brings over 20 years of commercial launch experience in ophthalmology, focused on building, launching, and evolving significant brands, notably in the buy-and-bill specialty pharma model. At SpyGlass Pharma, he will build and lead the marketing function for the company as it continues to progress the Bimatoprost Drug Pad-IOL System (BIM-IOL System) through Phase 3 clinical trials and towards potential commercialization upon FDA approval.</p> <p>“We http://www.streetinsider.com/Globe+Newswire/SpyGlass+Pharma+Appoints+Mike+Pinder+as+Vice+President%2C+Marketing/26587758.html Tue, 02 Jun 2026 08:00:00 -0400 A.24505702 O.21568879 SGP http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+to+Participate+in+Upcoming+Investor+Conferences/26531600.html <p align="left">ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences:</p> <p><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Date: Tuesday, May 26, 2026<br/>Time: 2:00 p.m. ET<br/>Format: Fireside Chat</p> <p><strong>Jefferies Global Healthcare Conference</strong><br/>Date: Thursday, June 4, 2026<br/>Time: 2:35 p.m. ET<br/>Format: Fireside Chat</p> <p><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference</strong><br/>Date: Wednesday, June 10, 2026<br/>Time: 10:40 a.m. ET<br/>Format: Corporate Presentation</p> <p>A live webcast and subsequent replay of each presentation can be accessed http://www.streetinsider.com/Press+Releases/SpyGlass+Pharma+to+Participate+in+Upcoming+Investor+Conferences/26531600.html Thu, 21 May 2026 08:00:00 -0400 SGP